Key result
A historical review of pacemaker and implantable cardioverter-defibrillator development highlights the importance of clinical data and balancing innovation with device reliability.
Understanding the history and clinical data of pacemaker and ICD development offers insights into future cardiovascular device innovation and reliability.
Emphasizes rigorous clinical evaluation for new CIEDs; leaves open optimal strategies for balancing innovation and reliability.
Pacemaker (PM) and implantable cardioverter-defibrillator (ICD) therapy are two examples of remarkable technological advances that have revolutionized cardiovascular device therapy. Understanding the history of early PM and ICD device development, recognizing the importance of the clinical data that was required to launch the current "era" of exponential device use, and appreciating the challenge of maintaining device innovation without sacrificing device reliability, are important lessons that may offer insights into future cardiovascular device development.
No takes yet. Share an insight, caveat, or question.
William H. Maisel (2005) conducted a review in Cardiovascular device therapy. Pacemaker and implantable cardioverter-defibrillator (ICD) therapy was evaluated. A historical review of pacemaker and implantable cardioverter-defibrillator development highlights the importance of clinical data and balancing innovation with device reliability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: